The BSH team would like to extend our warmest wishes and gratitude to Dr Josh Wright, who stepped down as BSH President after completing his two year term at the Annual Scientific Meeting in Liverpool on Tuesday 30 April.
Josh has been on the Boar...
1 year ago
A new gene editing therapy for sickle cell disease and β-thalassaemia showed benefits for more than 90% of patients, according to the final results of the first clinical trials.
Exagamglogene autotemcel (exa-cel) received regulatory approval in th...
1 year ago
